Human medicines European public assessment report (EPAR): Phelinun, melphalan, Date of authorisation: 16/11/2020, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Cyramza, ramucirumab, Date of authorisation: 19/12/2014, Revision: 21, Status: Authorised

Medicinal products for human use: monthly figures - May 2025

Fourth European Medicines Agency and Affordable Medicines Europe bilateral meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, 1 July 2025

Human medicines European public assessment report (EPAR): Aripiprazole Zentiva, aripiprazole, Date of authorisation: 25/06/2015, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR): Trumenba, meningococcal group b vaccine (recombinant, adsorbed), Date of authorisation: 24/05/2017, Revision: 21, Status: Authorised

Human medicines European public assessment report (EPAR): Noxafil, posaconazole, Date of authorisation: 25/10/2005, Revision: 42, Status: Authorised

Human medicines European public assessment report (EPAR): Aspaveli, pegcetacoplan, Date of authorisation: 13/12/2021, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR): TachoSil, human fibrinogen,human thrombin, Date of authorisation: 08/06/2004, Revision: 27, Status: Authorised

Human medicines European public assessment report (EPAR): Xevudy, sotrovimab, Date of authorisation: 17/12/2021, Revision: 22, Status: Authorised